JP2017131682A5 - - Google Patents

Download PDF

Info

Publication number
JP2017131682A5
JP2017131682A5 JP2017050041A JP2017050041A JP2017131682A5 JP 2017131682 A5 JP2017131682 A5 JP 2017131682A5 JP 2017050041 A JP2017050041 A JP 2017050041A JP 2017050041 A JP2017050041 A JP 2017050041A JP 2017131682 A5 JP2017131682 A5 JP 2017131682A5
Authority
JP
Japan
Prior art keywords
cells
hours
liver
found
control
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017050041A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017131682A (ja
JP6891010B2 (ja
Filing date
Publication date
Priority claimed from JP2013509287A external-priority patent/JP6177687B2/ja
Application filed filed Critical
Publication of JP2017131682A publication Critical patent/JP2017131682A/ja
Priority to JP2019113597A priority Critical patent/JP6987811B2/ja
Publication of JP2017131682A5 publication Critical patent/JP2017131682A5/ja
Application granted granted Critical
Publication of JP6891010B2 publication Critical patent/JP6891010B2/ja
Priority to JP2021194048A priority patent/JP7358441B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017050041A 2010-05-07 2017-03-15 実質組織からの細胞の移植方法 Expired - Fee Related JP6891010B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2019113597A JP6987811B2 (ja) 2010-05-07 2019-06-19 細胞の凍結保存方法
JP2021194048A JP7358441B2 (ja) 2010-05-07 2021-11-30 膵臓に細胞を移植するための薬剤の製造のための混合物の使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33244110P 2010-05-07 2010-05-07
US61/332,441 2010-05-07
JP2013509287A JP6177687B2 (ja) 2010-05-07 2011-05-06 実質組織からの細胞の移植用医薬の製造に用いられる混合物の使用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2013509287A Division JP6177687B2 (ja) 2010-05-07 2011-05-06 実質組織からの細胞の移植用医薬の製造に用いられる混合物の使用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019113597A Division JP6987811B2 (ja) 2010-05-07 2019-06-19 細胞の凍結保存方法

Publications (3)

Publication Number Publication Date
JP2017131682A JP2017131682A (ja) 2017-08-03
JP2017131682A5 true JP2017131682A5 (enExample) 2019-08-08
JP6891010B2 JP6891010B2 (ja) 2021-06-18

Family

ID=44902076

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2013509287A Expired - Fee Related JP6177687B2 (ja) 2010-05-07 2011-05-06 実質組織からの細胞の移植用医薬の製造に用いられる混合物の使用
JP2017050041A Expired - Fee Related JP6891010B2 (ja) 2010-05-07 2017-03-15 実質組織からの細胞の移植方法
JP2019113597A Expired - Fee Related JP6987811B2 (ja) 2010-05-07 2019-06-19 細胞の凍結保存方法
JP2021194048A Active JP7358441B2 (ja) 2010-05-07 2021-11-30 膵臓に細胞を移植するための薬剤の製造のための混合物の使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2013509287A Expired - Fee Related JP6177687B2 (ja) 2010-05-07 2011-05-06 実質組織からの細胞の移植用医薬の製造に用いられる混合物の使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2019113597A Expired - Fee Related JP6987811B2 (ja) 2010-05-07 2019-06-19 細胞の凍結保存方法
JP2021194048A Active JP7358441B2 (ja) 2010-05-07 2021-11-30 膵臓に細胞を移植するための薬剤の製造のための混合物の使用

Country Status (19)

Country Link
US (1) US20110274666A1 (enExample)
EP (1) EP2566567A4 (enExample)
JP (4) JP6177687B2 (enExample)
KR (4) KR102493613B1 (enExample)
CN (2) CN111281890A (enExample)
AR (1) AR081906A1 (enExample)
AU (1) AU2011247984B2 (enExample)
BR (1) BR112012028265B1 (enExample)
CA (2) CA2798458C (enExample)
CL (1) CL2012003085A1 (enExample)
CR (1) CR20120603A (enExample)
IL (3) IL222857A (enExample)
MX (3) MX359678B (enExample)
NZ (2) NZ630598A (enExample)
PH (1) PH12012502176A1 (enExample)
RU (1) RU2736955C2 (enExample)
SG (2) SG10201503582YA (enExample)
TW (3) TW201202424A (enExample)
WO (1) WO2011140428A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013010045A1 (en) 2011-07-12 2013-01-17 Biotime Inc. Novel methods and formulations for orthopedic cell therapy
US8961617B2 (en) * 2012-03-08 2015-02-24 Liventa Bioscience, Inc. Amnion and chorion constructs and uses thereof in abdominal surgery
US9533013B2 (en) 2013-03-13 2017-01-03 University Of North Carolina At Chapel Hill Method of treating pancreatic and liver conditions by endoscopic-mediated (or laparoscopic-mediated) transplantation of stem cells into/onto bile duct walls of particular regions of the biliary tree
EP2886644A1 (en) 2013-12-20 2015-06-24 Kallistem Process for implementing in vitro spermatogenesis and associated device
US10765705B2 (en) 2014-11-24 2020-09-08 Prime Merger Sub, Llc Visco-supplement compositions, and methods of use thereof
US20160213714A1 (en) * 2015-01-23 2016-07-28 Everon Biosciences, Inc. Induction of cellular senescence for tissue therapies
CN106148266A (zh) * 2015-04-20 2016-11-23 烟台赛泽生物技术有限公司 一种免疫细胞用培养基及该培养基的添加剂
JP2016209303A (ja) * 2015-05-08 2016-12-15 レジエンス株式会社 肝組織を再生するための製剤
US20170369849A1 (en) * 2016-05-11 2017-12-28 The University Of North Carolina At Chapel Hill Compositions and methods for bioengineered tissues
EP3520746A4 (en) 2016-09-30 2020-05-06 Taipei Veterans General Hospital FREEZER PROTECTION AGAINST PROTECTING BIOLOGICAL TISSUE DURING FREEZER TREATMENT AND MANUFACTURING METHOD THEREFOR
CN110913691A (zh) * 2017-04-06 2020-03-24 北卡罗来纳大学教堂山分校 低温保存方法
KR20200028391A (ko) * 2017-06-12 2020-03-16 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 세포 생착용 패치 이식편 조성물
IL306070A (en) 2018-05-03 2023-11-01 Collplant Ltd Dermal fillers and their uses
JP2020050625A (ja) 2018-09-27 2020-04-02 株式会社北里コーポレーション 卵巣組織の移植方法および卵胞活性化方法
JP7350505B2 (ja) * 2019-02-15 2023-09-26 イビデン株式会社 生体試料を含む固化体
WO2021060380A1 (ja) * 2019-09-27 2021-04-01 公立大学法人横浜市立大学 肝細胞の可塑性誘導法
CN117337309A (zh) * 2021-04-09 2024-01-02 威廉马歇莱思大学 用于诊断和治疗的细胞和颗粒在表面上的界面接种
JPWO2023042875A1 (enExample) * 2021-09-16 2023-03-23
US20250154453A1 (en) * 2021-12-28 2025-05-15 Pormedtec Co., Ltd. Method for producing transplant material, and transplant material
WO2024043306A1 (ja) * 2022-08-24 2024-02-29 株式会社ヴィータ 蛍光標識用組成物、蛍光プローブ、注入剤、シリンジ充填物、医療器具、医療用繊維素材、蛍光標識用組成物の製造方法、及び医療用繊維素材の製造方法
CN116920263B (zh) * 2023-07-28 2026-04-21 南方医科大学南方医院 一种透皮递送活体干细胞的冷冻微针及其制备方法和应用
CN117426368A (zh) * 2023-10-08 2024-01-23 北京汇智泰康医药技术有限公司 一种肝细胞冻存液及其应用

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6231881B1 (en) * 1992-02-24 2001-05-15 Anton-Lewis Usala Medium and matrix for long-term proliferation of cells
US20040138329A1 (en) * 1992-04-20 2004-07-15 Board Of Regents Of The University Of Texas System Gels for encapsulation of biological materials
EP0655910A4 (en) * 1992-07-29 1996-02-28 Univ Washington USE OF A BAG FOR IMPLANTING LIVING CELLS.
US5709854A (en) * 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5681587A (en) * 1995-10-06 1997-10-28 Desmos, Inc. Growth of adult pancreatic islet cells
US6482231B1 (en) * 1995-11-20 2002-11-19 Giovanni Abatangelo Biological material for the repair of connective tissue defects comprising mesenchymal stem cells and hyaluronic acid derivative
AU3214797A (en) * 1996-05-28 1998-01-05 Regents Of The University Of Michigan, The Engineering oral tissues
US6224893B1 (en) * 1997-04-11 2001-05-01 Massachusetts Institute Of Technology Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
JP3014343B2 (ja) * 1997-06-06 2000-02-28 科学技術振興事業団 肝細胞の培養方法
IT1293484B1 (it) * 1997-06-11 1999-03-01 Fidia Advanced Biopolymers Srl Materiale biologico comprendente una efficiente coltura di cellule e una matrice tridimensionale biocompatibile e biodegradabile
US6129911A (en) * 1998-07-10 2000-10-10 Rhode Island Hospital, A Lifespan Partner Liver stem cell
KR100873690B1 (ko) * 1999-01-19 2008-12-12 유니버시티 오브 노스캐롤라이나 앳 채플 힐 인간 간 전구세포
US6592623B1 (en) * 1999-08-31 2003-07-15 Virginia Commonwealth University Intellectual Property Foundation Engineered muscle
US6365385B1 (en) * 1999-03-22 2002-04-02 Duke University Methods of culturing and encapsulating pancreatic islet cells
WO2000066036A2 (en) * 1999-04-30 2000-11-09 Massachusetts General Hospital Fabrication of vascularized tissue using microfabricated two-dimensional molds
US6660905B1 (en) * 1999-07-14 2003-12-09 The Board Of Trustees Of The Leland Stanford Junior University Mice comprising engrafted functional human hepatocytes
US6960576B2 (en) 1999-09-13 2005-11-01 Bristol-Myers Squibb Pharma Company Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production
RU2165263C1 (ru) * 2000-06-23 2001-04-20 Зыбин Дмитрий Владимирович Способ лечения сахарного диабета
US7291673B2 (en) * 2000-06-02 2007-11-06 Eidgenossiche Technische Hochschule Zurich Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
US6435190B1 (en) * 2000-06-14 2002-08-20 Syde A. Taheri Autogenous cell patch cardio myoplasty and advanced muscle graft implantation system
MY130475A (en) * 2000-08-25 2007-06-29 Contura As Polyacrylamide hydrogel and its use as an endoprosthesis
AU2002219935A1 (en) * 2000-11-28 2002-06-11 Focal, Inc. Polyalkylene glycol viscosity-enhancing polymeric formulations
WO2003022046A1 (en) * 2001-09-10 2003-03-20 University Of Saskatchewan Technologies Inc. Method for cryopreserving mammalian cells and tissues
US20040191225A1 (en) * 2002-08-06 2004-09-30 Dinsmore Jonathan H. Injection system
US7319035B2 (en) * 2002-10-17 2008-01-15 Vbi Technologies, L.L.C. Biological scaffolding material
EP1624751A2 (en) * 2003-05-08 2006-02-15 Cellartis AB Cryopreservation of human blastocyst-derived stem cells by use of a closed straw vitrification method
WO2005021730A2 (en) * 2003-09-02 2005-03-10 University Of North Carolina At Chapel Hill Biodegradable polymer-ligand conjugates and their uses in isolation of cellular subpopulations and in cryopreservation, culture and transplantation of cells
KR20060067974A (ko) * 2003-09-19 2006-06-20 뉴사우스 이노베이션즈 피티와이 리미티드 간세포의 분리 방법
WO2005056763A2 (en) * 2003-12-04 2005-06-23 University Of Utah Research Foundation Process and formulation to improve viability of stored cells and tissue
US7884185B2 (en) * 2004-07-28 2011-02-08 University Of Delaware Hydrogels and uses thereof
US8828433B2 (en) * 2005-04-19 2014-09-09 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
BRPI0618724A2 (pt) * 2005-11-16 2011-09-06 Univ North Carolina componentes da matriz extracelular para expansão ou diferenciação de progenitores hepáticos
WO2007138119A1 (es) * 2006-05-30 2007-12-06 Instituto Nacional De Investigación Y Tecnología Agraria Y Alimentaria, Inia Procedimiento de preparación de vesículas unilamelares para la criopreservación y cultivo de celulas germinales y embriones
TW200817019A (en) * 2006-07-10 2008-04-16 Univ Columbia De novo formation and regeneration of vascularized tissue from tissue progenitor cells and vascular progenitor cells
GB2455041B (en) * 2006-09-21 2012-03-07 Purdue Research Foundation Collagen preparation and method of isolation
US20080233088A1 (en) * 2007-02-16 2008-09-25 Varian Medical Systems Technologies, Inc. Preparative regimen for engraftment, growth and differentiation of non-hematopoeitic cells in vivo after transplantation
BRPI0808696A2 (pt) * 2007-03-06 2015-06-23 Univ North Carolina Complexos de hiluronanas, outros componentes de matriz, hormônios e fatores de crescimento para manutenção, expansão e/ou diferenciação de células
US20080299177A1 (en) * 2007-06-06 2008-12-04 Biovaluation & Analysis, Inc. Supramolecular Complexes for Use in Acoustically Mediated Intracellular Drug Delivery in vivo
TW200916581A (en) * 2007-06-15 2009-04-16 Univ North Carolina Paracrine signals from mesenchymal feeder cells and regulating expansion and differentiation of hepatic progenitors using same
GB0713079D0 (en) * 2007-07-05 2007-08-15 Ucl Business Plc biomaterial scaffolds with defined stiffness
WO2009022339A1 (en) * 2007-08-15 2009-02-19 Ramot At Tel Aviv University Ltd. Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair
CA2696698A1 (en) * 2007-08-20 2009-02-26 Do-Coop Technologies Ltd. Enriched nanostructure composition
EP2222159B1 (en) * 2007-11-20 2018-02-21 Pioneer Surgical Orthobiologics, Inc. Cryopreservation of cells using cross-linked bioactive hydrogel matrix particles
CN101618235A (zh) * 2008-07-01 2010-01-06 中国人民解放军军事医学科学院基础医学研究所 一种基于opf水凝胶为液态支架的可注射性心肌组织工程产品
WO2010027471A2 (en) * 2008-09-04 2010-03-11 The General Hospital Corporation Hydrogels for vocal cord and soft tissue augmentation and repair
US20100092533A1 (en) * 2008-10-15 2010-04-15 Joshua Stopek Bioabsorbable Surgical Composition
EP2221362A1 (en) * 2009-02-19 2010-08-25 Naturin GmbH & Co Method for the cryopreservation of cells, artificial cell constructs or three-dimensional complex tissues assemblies

Similar Documents

Publication Publication Date Title
CL2012002882A1 (es) Compuestos derivados de 5,7- sustituido -imidazol [1,2-c] pirimidinas, inhibidores de jak-quinasa; proceso de preparacion; composicion farmaceutica; y su uso para tratar una enfermedad autoinmunitaria o inflamatoria, el rechazo de transplante de organos, tejidos o celulas en un mamifero.
WO2009115581A3 (en) Improved cryopreservation of adipose tissue for the isolation of mesenchymal stem cells
WO2012021845A3 (en) Improved hematopoietic stem and progenitor cell therapy
WO2011117258A3 (en) Methods of increasing efficiency of vector penetration of target tissue
BRPI0813729B8 (pt) métodos de preparação de massas celulares de cardiomiócitos purificados derivados de células-tronco pluripotentes e de uma película de massas celulares de cardiomiócitos, bem como dispositivo médico e uso das referidas massas celulares
JP2018518943A5 (enExample)
WO2016070166A3 (en) Messenger una molecules and uses thereof
CL2009001476A1 (es) Compuestos derivados de 2,4-diamin-n2-fenil pirimidina sustituidos, mediadores de la inhibicion de igf-1r; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de enfermedades autoinmune, por trasplante, infecciosas o un trastorno proliferativo celular.
JP2014501518A5 (enExample)
EA201890137A1 (ru) Среда для культивирования клеток с добавлением таурина и способы применения
EP1910519A4 (en) IMMUNOPHÄNOTYP AND IMMUNOGENICITY OF HUMAN CELLS FROM FAT TISSUE
WO2017105565A3 (en) Compositions for therapeutics, targeted pet imaging and methods of their use
EP4692350A3 (en) Compositions and methods for induced tissue regeneration in mammalian species
NZ630598A (en) Method of engrafting cells from solid tissues
IL260210B2 (en) cftr regulators and methods of using them
WO2016191179A8 (en) In vitro models of regenerative muscle cell therapy and uses thereof
MX2021012041A (es) Metodos para promover la diferenciacion de celulas epiteliales timicas y progenitores de celulas epiteliales timicas de celulas madre pluripotentes, celulas resultantes y usos de estas.
MX373950B (es) USO DE UN INHIBIDOR TEMPORAL DE UN GEN p53 PARA LA PROFILAXIS DE LESIÓN POR ISQUEMIA-REPERFUSIÓN.
BR112012030015A2 (pt) composição para a preservação de órgãos a frio, método para a preparação de uma composição de preservação de órgãos a frio, uso da cardiotrofina-1 ou uma variante equivalente funcionalmente da mesma, método para a preservação de órgãos a frio, órgão isolado preservado a frio e kit para a preparação de uma composição para a preservação de órgãos a frio
JP2016510766A5 (enExample)
WO2006107850A3 (en) Preventing rejection of transplanted tissue using regulatory t cells
CY1112746T1 (el) Κρυοσυντηρηση ηπατοκυτταρων
EP3543331A4 (en) CELL POPULATION CONTAINING MESENCHYMAL STEM CELLS DERIVED FROM F RATE APPENDICES, METHOD FOR PRODUCING THE SAME, AND MEDICINAL COMPOSITION
JP2010166901A5 (enExample)
RU2011103549A (ru) Предшественник искусственной почки и способ его получения